Current status of therapeutic drug monitoring in mental health treatment: A review
Therapeutic drug monitoring (TDM) receives growing interest in different psychiatric clinical
settings (emergency, inpatient, and outpatient services). Despite its usefulness, TDM …
settings (emergency, inpatient, and outpatient services). Despite its usefulness, TDM …
[HTML][HTML] CYP2C19 Genetic Variants and Major Depressive Disorder: A Systematic Review
LSS Bonasser, CMS Silva, CF Fratelli, BR Gontijo… - Pharmaceuticals, 2024 - mdpi.com
Major depressive disorder (MDD) affects over 300 million people globally and has a
multifactorial etiology. The CYP2C19 enzyme, involved in metabolizing certain …
multifactorial etiology. The CYP2C19 enzyme, involved in metabolizing certain …
[HTML][HTML] 野芭蕉对经皮冠状动脉介入术CYP2C19 基因中间代谢表型患者的疗效观察
潘兴寿， 李近都， 梁烨， 蔡键， 班青丽， 卢国康… - Advances in Clinical …, 2023 - hanspub.org
作者: 潘兴寿, 李天资: 右江民族医学院附属医院心血管内科, 广西百色; 李近都:
广西医科大学附属肿瘤医院肝胆外科, 广西南宁; 梁烨: 右江民族医学院附属医院教学部 …
广西医科大学附属肿瘤医院肝胆外科, 广西南宁; 梁烨: 右江民族医学院附属医院教学部 …
[PDF][PDF] Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review. Pharmaceutics 2022, 14, 2674
Therapeutic drug monitoring (TDM) receives growing interest in different psychiatric clinical
settings (emergency, inpatient, and outpatient services). Despite its usefulness, TDM …
settings (emergency, inpatient, and outpatient services). Despite its usefulness, TDM …